Thrombosis history was not predictive of overall survival in patients with pulmonary hypertension risk and PV, a study found. In findings arterial thrombosis carried worse overall survival than venous thrombosis in this patient population. Clinical data is limited in areas such as how to evaluate bleeding risk and when to apply mechanical thromboprophylaxis. The new agent is on the 505(b)(2) regulatory pathway and was compared with tablet-form apixaban in 60 healthy volunteers. VRd was associated with lower rates of venous thromboembolism versus KRd in patients with newly-diagnosed multiple myeloma. Intracardiac thrombosis in patients with COVID-19 was associated with increased all-cause and cardiovascular mortality. Patients treated for isolated superficial vein thrombosis with anticoagulants still had a "substantial" risk of VTE later on. Splenomegaly and myeloproliferative disorders increased risk for porto-spleno-mesenteric venous thrombosis after splenectomy. Edoxaban therapy for 12 months was superior to three-month therapy for preventing venous thromboembolisms and related deaths. Subclinical leaflet thrombosis appears more common after TAVR versus SAVR, but was not associated with increased stroke risk. In the second half of a two-part interview, DocWire News partner Hady Lichaa, MD, FACC, FSCAI, FSVM, RPVI, spoke with ... In part one of a two-part interview, DocWire News partner Hady Lichaa, MD, FACC, FSCAI, FSVM, RPVI, sits down with ... It’s another session of CardioNerds Rounds! In these rounds, Dr. Priya Kothapalli (Interventional FIT at University of ... DocWire News recently spoke with Dan Bloomfield, MD, FACC, FAHA, Chief Medical Officer of Anthos Therapeutics. Dr. ... Researchers assessed the UK experience of kidney transplantations from deceased donors who had vaccine-induced immune ... In a study in Research and Practice in Thrombosis and Haemostasis, researchers examined changes in clinical and platelet ... Therapies that can reduce risk of thrombosis without increasing bleeding complications are needed to improve stroke ... Apixaban has been shown to be effective for preventing venous thromboembolism (VTE) in patients with cancer, but is ... Recently, the CHEETAH study (initiated in 2019), the first large study to demonstrate the safety ... Nephrotic-range proteinuria is a common reason for nephrological consultation. However, the differential diagnosis is ...